Immuron Ltd ADR (IMRN)vsRevolution Medicines Inc (RVMD)
IMRN
Immuron Ltd ADR
$1.08
-1.37%
HEALTHCARE · Cap: $9.93M
RVMD
Revolution Medicines Inc
$180.92
-1.60%
HEALTHCARE · Cap: $39.58B
Smart Verdict
WallStSmart Research — data-driven comparison
Immuron Ltd ADR generates 908% more annual revenue ($7.48M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -62.1%. IMRN earns a higher WallStSmart Score of 28/100 (F).
IMRN
Avoid28
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
4.8% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : IMRN
The strongest argument for IMRN centers on Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : IMRN
The primary concerns for IMRN are Revenue Growth, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
IMRN profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.38 — expect wider price swings.
IMRN is growing revenue faster at 4.8% — sustainability is the question.
IMRN generates stronger free cash flow (-2M), providing more financial flexibility.
Bottom Line
IMRN scores higher overall (28/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Immuron Ltd ADR
HEALTHCARE · BIOTECHNOLOGY · USA
Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immunomodulated diseases in Australia, the United States and internationally. The company is headquartered in Carlton, Australia.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?